Bilten za hematologiju i transfuziju最新文献_第3页

[The effect of long-term plasmapheresis on the composition of blood. III. Changes in the concentration of total, direct and indirect bilirubin, alkaline phosphatase, serum transaminases (SGOT, SGPT). total lipids, triglycerides and cholesterol]. 长期血浆置换对血液成分的影响。3总胆红素、直接胆红素、间接胆红素、碱性磷酸酶、血清转氨酶(SGOT、SGPT)的变化。总脂质，甘油三酯和胆固醇]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

D Grgicević

引用次数: 0

[Interaction of the parasitic antigen cytolipin P with erythrocyte factor P1]. [寄生虫抗原胞脂素P与红细胞因子P1的相互作用]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

T Hrzenjak, D Zlatko, L D Mirjana

{"title":"[Interaction of the parasitic antigen cytolipin P with erythrocyte factor P1].","authors":"T Hrzenjak, D Zlatko, L D Mirjana","doi":"","DOIUrl":"","url":null,"abstract":"Glycolipid compounds causing agglutination of erythrocytes in vitro and the appearance of the anti-P-antibodies in vivo have been named P antigens. The P denotes blood group factor P, being the antigen belonging to multiple allelomorphs in the P system. Their structure has been shown to be of glycosphingolipid nature differing in number and character from carbohydrate components. It has been established that at infestations by parasites the titre of the anti-P-antibodies increases, and hydatid fluid from the cysts of Echinococcus granulosus, as well as certain tissue extracts of some helminths inhibit agglutination of the P1-erythrocytes by anti-P1--antisera. We have isolated the very polar glycolipid complex from hydatid fluid of the cysts of Echinococcus granulosus and from the tissue homogenates of some parasite helminths. We have named it as cytolipin P, designating by P its parasitic origin. The complex is immunologically active and induces cellular and humoral immune response. Having taken into account the nature of cytolipin P we investigated its biological relation to blood group P-factor. Equine, sheep and human p1-erythrocytes agglutinate the cytolipin P when the concentration of it reaches 75--100 mg%. The inhibition of agglutination was achieved by four sequential doses inducing haemagglutination with anti-P-sera when used as standards, and with human anti-P1-sera of the patients exhibiting echinococcal and ascardial positive human and animal sera. Inhibition was reached two times quicker with anticytolipin-P-sera. It would appear that in the organisms invaded by parasites the cytolipin P represents that antigenic structure which provokes the organism to produce the polyclonal anti-P-antibodies.","PeriodicalId":75595,"journal":{"name":"Bilten za hematologiju i transfuziju","volume":"11 2-3","pages":"33-8"},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17735421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Results of the therapy of acute leukemia during 10 years (1972-1982)]. [1972-1982年10年急性白血病治疗结果]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

N Krpan-Antonin, M Smokvina

引用次数: 0

[A case report of prolonged hemolytic anemia in an infant due to a partial exchange transfusion]. [部分换血导致婴儿长期溶血性贫血1例报告]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

K Vujaklija-Stipanović, M Smokvina, V Girotto, O Beleznay

引用次数: 0

[Levels of serum complement and immunocomplexes in HBs antigen positive blood donors]. [HBs抗原阳性献血者血清补体和免疫复合物水平]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

J Milosavljević, S Gruden

引用次数: 0

[Preleukemia]. [白血病前期]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

D Janić, E Stojimirović

{"title":"[Preleukemia].","authors":"D Janić, E Stojimirović","doi":"","DOIUrl":"","url":null,"abstract":"Case reports dealing with preleukemic syndromes are rare. During the last years preleukemia has been ill defined. Nowadays, most authors agree that a marrow stem disorder with clinically recognisable haematological abnormalities, which proceed the development of overt leukemia, is to be regarded as preleukemia syndrome. Clinical and haematological features are different in preleukemic syndromes terminating with acute lymphoblastic (ALL) and acute non-lymphoblastic leukemia (ANLL). We describe two cases of preleukemia--the first evolving into ALL and the second into ANLL. Our first patient had developed pancytopenia and hypocellular bone marrow five months before overt ALL. In the moment the diagnosis was made clinical examination revealed enlarged lymph glands, liver and spleen. Laboratory tests showed pancytopenia and bone marrow infiltrated with blasts L1 morphology (F. A. B. classification). Preleukemic phase terminating with ANLL featured pancytopenia and hypercellular bone marrow infiltrated with histiocytes, some showing signs of erythrocyte-, leukocyte- and platelet-ingestion. Diagnosis of acute monoblastic leukemia M5 (F. A. B.) was made three months after the illness onset, according to bone marrow infiltration with monoblasts. Clinical and haematological features helpful in the recognition of preleukemic syndromes are discussed.","PeriodicalId":75595,"journal":{"name":"Bilten za hematologiju i transfuziju","volume":"11 2-3","pages":"97-103"},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17650814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Transplantation of bone marrow]. [骨髓移植]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

S Stefanović

引用次数: 0

[Positive feedback mechanisms by which immunoproliferative tumors stimulate their own growth]. [免疫增生性肿瘤刺激自身生长的正反馈机制]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

B Pekić, M Popović, K Pavelić, V Bratić-Mikes

{"title":"[Positive feedback mechanisms by which immunoproliferative tumors stimulate their own growth].","authors":"B Pekić, M Popović, K Pavelić, V Bratić-Mikes","doi":"","DOIUrl":"","url":null,"abstract":"Based on clinical findings of patients with some proliferative tumors and experimental data, a hypothesis of positive feedback mechanism by which tumor stimulates its own growth has been formulated. In some patients with Hodgkin's disease and non-Hodgkin's lymphomas, i.e. leukemias, the high levels of substances immunologically cross reactive with insulin (SICRI), low glycemic values and increased values of growth hormone were found in the blood. These findings were in correlation with the status and stages of the disease. In a more advanced stage of the disease, the concentration of insulin-like substances was higher and glucose levels were lower in patients in remission. The high correlation was found between the increased SICRI levels of insulin-like substances showed faster growth. It is certain that some tumor cells excrete these substances. In mice with melanomas, high concentrations of these substances, growth hormone and low glucose levels were found in the blood. On the basis of these findings a hypothesis was formulated about positive feedback mechanism by which tumors stimulates their own growth. Tumor excretes SICRI which decreases glucose concentration in the blood. Hypoglycemia is a stimulation for the pituitary to release growth hormone into the blood. This hormone probably stimulates protein synthesis and replication of tumor cells contributing to increased SICRI excretion, etc. The final results of this positive feedback mechanism is faster growth of tumor and death of host.","PeriodicalId":75595,"journal":{"name":"Bilten za hematologiju i transfuziju","volume":"11 2-3","pages":"23-31"},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17449858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Hairy cell leukemia. Personal experience with 11 cases]. 毛细胞白血病。个人经验11例]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

T Stojcevski, A Stojanović, R Saso

{"title":"[Hairy cell leukemia. Personal experience with 11 cases].","authors":"T Stojcevski, A Stojanović, R Saso","doi":"","DOIUrl":"","url":null,"abstract":"Clinical and morphologic characteristics of hairy cell leukemia at 11 patients have been analyzed. The frequency of this disorder is 2.5% from all leukemias. This disorder is often retrospectively diagnosed--at 7 cases from our study. the disorder is often retrospectively diagnosed--older age (78%). Splenomegaly is the main clinical manifestation, at all 11 patients. Pancytopenia is frequent finding but at 4 patients the leucocyte count was over 10 X 10(9)/1 in the beginning. Hairy cells, although not always with typical appearance, in 90% of the cases are found in peripheral blood over 10%. Bone marrow biopsy cytological and hystological findings at 9 patients were typical for diagnosis. Fibrosis was present in 6 specimens. At 7 patients diagnosis was confirmed with histological examinations of lymphocyte concentrates from peripheral blood on thin and ultrathin sections, as well as with electron microscopy characteristic appearance of hairy cells. Pneumonia as complication was registered in 24 occasions, gastro-intestinal infections at 9, haemorrhagic syndrome at 4 and skin carcinoma at 2 cases. Treatment was variable--2 patients were observed for more than 50 months, 2 were splenectomised, of which one with complete remission longer than a year, while from 8 treated with COP protocol, complete remission was obtained in 5 (62%) patients, and two treated with CHOP protocol entered complete remission for longer than 12 months. Average survival is 51 months (2--144). Three (28%) patients died.","PeriodicalId":75595,"journal":{"name":"Bilten za hematologiju i transfuziju","volume":"11 2-3","pages":"59-69"},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17734264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[4th Yugoslav Symposium on Pediatric Hematology. Belgrade, 1983. Abstracts]. 第四届南斯拉夫儿童血液学研讨会。贝尔格莱德,1983。摘要]。

Bilten za hematologiju i transfuziju Pub Date : 1983-01-01

引用次数: 0